Within two days, patients are cured of the disease and no longer transmit the parasite if they are bitten again by a mosquito.
This discovery was made by Radboud university medical center scientists and international colleagues during a research project conducted in Mali. The results will be published in The Lancet Infectious Diseases on February 6th.
The pressure is on when it comes to antimalarial medicines, as malaria parasites are increasingly resistant to the artemisinin-based combination therapies that are currently used. In addition, these medicines do very little to stop the spread of malaria, as the parasites remain in the blood for a long time, with the chance that other mosquitos are infected if they feed on the patient. The parasites split in the patient’s red blood cells, forming male and female sex cells (gametocytes). If another mosquito bites the patient, it sucks up the sex cells and these are fertilized in the mosquito’s stomach. The offspring then find their way to the mosquito’s salivary glands, where the cycle starts again.
Effect after just 48 hours
The gametocytes can stay in a person’s body for several weeks following treatment for malaria. In the new study in Mali, Radboudumc researchers added methylene blue to the artemisinin-based combination therapy. Methylene blue is a blue dye that is used in laboratories to distinguish dead cells from living cells. Adding the dye to the antimalaria medicine ensured that patients no longer infected other mosquitos, within as little as 48 hours. Patients who were not given methylene blue were able to infect other mosquitos for at least a week. Researcher Teun Bousema (Radboudumc) coordinated the study which was conducted together with the University of California (UCSF) and the Malaria Research and Training Center (MRTC). Bousema: “We noted that the male parasites disappeared from the bloodstream more quickly than the female parasites.”
Encouraged by the promising results of laboratory experiments, Bousema’s team has investigated for the first time the effect of methylene blue on the spread of malaria amongst humans. Bousema: “Methylene blue is very promising, because it can prevent the spread of malaria within such a short time following treatment. There are also indications that methylene blue also works well in species that are resistant to certain medicines.” The dye is safe and was tolerated well by patients. There is however just one awkward side effect: “I have used it myself, and it turns your urine bright blue. This is something that we need to solve, because it could stop people from using it.”
Malaria causes 430?000 deaths every year. Infection is caused by the bite of a malaria-carrying mosquito, and 90% of all deaths are in Africa, mostly amongst children. Malaria prevention focuses primarily on the use of mosquito nets, insecticides and medicine and, as a result, the number of deaths due to malaria has almost halved in the last ten years.
The Latest on: Malaria parasites
via Google News
The Latest on: Malaria parasites
- Mass Drug Administrations to Protect Against Malaria on April 16, 2019 at 11:06 pm
but a major challenge to this goal is people carrying malaria parasites without showing any symptoms. ‘MDA could be a promising approach for reducing malaria burden, but its success depends mainly on ... […]
- Promising malaria vaccine to be tested in first large field trial on April 16, 2019 at 12:58 pm
PfSPZ works by eliciting an immune response against the malaria parasite Plasmodium falciparum. It is made of sporozoites (SPZ), the stage in the malaria parasite’s life cycle that infected mosquitoes ... […]
- Mass Drug Administrations Can Grant a Population Protection Against Malaria on April 16, 2019 at 9:30 am
but a major challenge to this goal is people carrying malaria parasites without showing any symptoms. One method to help clear all infections in a community is MDA, whereby everyone is asked to take ... […]
- After 30 years, Glaxo shows the right ‘PATH’ to eradicate malaria on April 16, 2019 at 9:21 am
The vaccine, developed with the non-profit organisation PATH, comes at a critical time and marks a milestone in the battle against the parasite that causes malaria. But the injection is a pioneer, not ... […]
- Mass drug administrations can grant population protection against malaria on April 16, 2019 at 7:57 am
but a major challenge to this goal is people carrying malaria parasites without showing any symptoms. One method to help clear all infections in a community is MDA, whereby everyone is asked to ... […]
- Malaria vaccination set to begin in Africa this month on April 16, 2019 at 7:21 am
The malaria parasite's uncanny ability to resist drugs and insecticides due to its complicated genes is making efforts to eliminate the disease more difficult. GlaxoSmithKline Plc invested $1 billion ... […]
- Malaria vaccine pilot programme to start in Africa this month on April 16, 2019 at 12:23 am
The technology is already being used to breed mosquitoes that spread sterility to deplete their numbers. The malaria parasite turns out to have greater genetic diversity than previously believed, ... […]
- Malaria Vaccine Took 30 Years. It's Still a Work in Progress on April 15, 2019 at 9:00 pm
The vaccine, developed with the non-profit organization PATH, comes at a critical time and marks a milestone in the battle against the parasite that causes malaria. But the injection is more pioneer ... […]
- Under the microscope: Ayush ministry’s dubious claims about Ayurvedic drugs for diabetes, malaria on April 14, 2019 at 8:07 pm
A Facebook post of Ministry of AYUSH claimed  that CCRAS has developed a drug called AYUSH-64 to counter the developing drug resistance to malaria parasite and the widespread nature of the ... […]
via Bing News